LXI-15028

· Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LXI-15028, covering 2020-04-08 to 2023-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer [Phase 3]